A drug administered to a patient for treatment, listed in SEER*Rx as a chemotherapeutic, hormonal or immunotherapy agent should be coded under chemotherapy [#1390], hormone therapy [#1400] or immunotherapy [#1410] regardless of the primary site(s) listed in SEER*Rx for that agent. Do not code under the data item, Other Therapy [NAACCR #1420]. Refer to the 2026 SEER manual for more information.

Search Database
Name Category Primary Site Code?
131I-MIBG Radiation See Remarks
5-Aza-2'Deoxy-cytidine Chemotherapy CML Yes
5-FP Chemotherapy Breast, gastric, head & neck, liver cancer Yes
ABT 888 Chemotherapy Ovary Yes
ADXS-HPV Biologic therapy (BRM, immunotherapy) Cervix Yes
AMG 531 Ancillary Agent No
ATRA-IV Differentiation inducing agent Lymphoma, Acute promyelocytic leukemia Yes
Abecma Biologic therapy (BRM, immunotherapy) Yes
Abemaciclib Chemotherapy Breast Yes
Abiraterone acetate Hormones and hormonal mechanisms Prostate Yes
Abraxane Chemotherapy Metastatic breast cancer, NSCLC, Non small cell lung cancer, cervix, melanoma, pancreas Yes
Acalabrutinib Chemotherapy Yes
Accutane Differentiation inducing agent Prostate cancer No
Acetaminophen Ancillary Agent No
Acetazolamide Ancillary Agent No
Acetylcysteine Ancillary Agent AIDS, Opportunistic infection No
Acitretin Differentiation inducing agent No
Acyclovir Ancillary Agent No
Acyclovir Sodium AIDS drug No
Ad5CMV-p53 (adenovirus p53) Biologic therapy (BRM, immunotherapy) Glioma, Head & neck, lung cancer No
Ado-trastuzumab emtansine Biologic therapy (BRM, immunotherapy) Metastatic HER-2 breast cancer Yes
Adrenocorticotropic hormone Hormones and hormonal mechanisms See Remarks
Adstiladrin Biologic therapy (BRM, immunotherapy) bladder Yes
Afinitor Chemotherapy breast, Lung, other cancer Yes
Akeega Chemotherapy Prostate See Remarks
Name Primary Site
7+3
ABCD
ABCM
ABD
ABDIC
ABVD
AC Breast
AC-T
ACOAP
ACOPP
ACT-FU-Cy
ACVBP
AD
ADE
ADM
ADOC
AIM
ALOMAD
APO regimen
ASHAP
ASHAP/M-BACOS
ATRA (263)
Adria-L-PAM
B-DOPA
BAC
Glossary